{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:22:04Z","timestamp":1793647324681,"version":"4.5.1"},"reference-count":81,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RR150093"],"award-info":[{"award-number":["RR150093"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","award":["18YOUN24"],"award-info":[{"award-number":["18YOUN24"]}],"id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["PC170570"],"award-info":[{"award-number":["PC170570"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH-17-PCRP-EIRA"],"award-info":[{"award-number":["W81XWH-17-PCRP-EIRA"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008762","name":"Genome Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001353","name":"Alexander and Margaret Stewart Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001353","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013114","name":"Broad Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013114","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50 CA090381"],"award-info":[{"award-number":["P50 CA090381"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P01 CA163227"],"award-info":[{"award-number":["P01 CA163227"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018746","name":"Shenzhen Gas Corporation","doi-asserted-by":"publisher","award":["1097737"],"award-info":[{"award-number":["1097737"]}],"id":[{"id":"10.13039\/501100018746","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["RI 2670\/1-1"],"award-info":[{"award-number":["RI 2670\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000192","name":"Ontario Ministry of Economic Development and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009744","name":"Eshelman Institute for Innovation, University of North Carolina at Chapel Hill","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009744","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012353","name":"Deutschen Konsortium f\u00fcr Translationale Krebsforschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012353","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016394","name":"Ludwig Center at Harvard","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016394","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["1122374"],"award-info":[{"award-number":["1122374"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals U.S.A.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016872","name":"Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016872","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015834","name":"Ono Pharma Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015834","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Chemical Biology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.chembiol.2020.10.001","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T10:44:40Z","timestamp":1603190680000},"page":"134-147.e14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["Modulating Androgen Receptor-Driven Transcription in Prostate Cancer with Selective CDK9 Inhibitors"],"prefix":"10.1016","volume":"28","author":[{"given":"Andr\u00e9","family":"Richters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0889-6959","authenticated-orcid":false,"given":"Shelby K.","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6826-2272","authenticated-orcid":false,"given":"David B.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Becky S.","family":"Leifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajjeev","family":"Jagannathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3053-8253","authenticated-orcid":false,"given":"Florian","family":"Kabinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u0161t Vrabi\u010d","family":"Koren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas B.","family":"Struntz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9967-0623","authenticated-orcid":false,"given":"Julie","family":"Urgiles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan A.","family":"Stagg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brice H.","family":"Curtin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deep","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Mathea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7946-4972","authenticated-orcid":false,"given":"Peter J.","family":"Mikochik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara D.","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7148-8179","authenticated-orcid":false,"given":"Hua","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4169-5753","authenticated-orcid":false,"given":"Jonathan R.","family":"Branch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Westover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles C.","family":"Bignan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0234-0039","authenticated-orcid":false,"given":"Brent A.","family":"Rupnow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen L.","family":"Karlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calla M.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Westbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9936-5610","authenticated-orcid":false,"given":"Chris M.","family":"Wilfong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6780-0358","authenticated-orcid":false,"given":"B. Wesley","family":"Trotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas C.","family":"Saffran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Bischofberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Knapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5481-0090","authenticated-orcid":false,"given":"Joshua W.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9167-0514","authenticated-orcid":false,"given":"Ian","family":"Hickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Bischoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco M.","family":"Gottardis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P.","family":"Balk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles Y.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius S.","family":"Pop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela N.","family":"Koehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2020.10.001_bib1","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/s41586-019-1318-9","article-title":"FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes","volume":"571","author":"Adams","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2020.10.001_bib2","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJMoa1315815","article-title":"AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer","volume":"371","author":"Antonarakis","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.chembiol.2020.10.001_bib3","unstructured":"Barsanti, P., Hu, C., Jin, J., Keyes, R., Kucejko, R., Lin, X., Pan, Y., Pfister, K., Sendzik, M., and Sutton, J. (2011). Pyridine and pyrazine derivatives as protein kinase modulators and their preparation and use for the treatment of CDK9-mediated diseases. PCT Int. Appl. 2011, WO 2010-EP60984; WO 2011012661 A1. SciFinder Scholar."},{"key":"10.1016\/j.chembiol.2020.10.001_bib4","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.chembiol.2010.07.012","article-title":"Halogen bonds form the basis for selective P-TEFb inhibition by DRB","volume":"17","author":"Baumli","year":"2010","journal-title":"Chem. Biol."},{"key":"10.1016\/j.chembiol.2020.10.001_bib5","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1038\/emboj.2008.121","article-title":"The structure of P-TEFb (CDK9\/cyclin T1), its complex with flavopiridol and regulation by phosphorylation","volume":"27","author":"Baumli","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.chembiol.2020.10.001_bib6","doi-asserted-by":"crossref","first-page":"42343","DOI":"10.18632\/oncotarget.16216","article-title":"Preclinical development of G1T38: a novel, potent and selective inhibitor of cyclin dependent kinases 4\/6 for use as an oral antineoplastic in patients with CDK4\/6 sensitive tumors","volume":"8","author":"Bisi","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.chembiol.2020.10.001_bib7","doi-asserted-by":"crossref","first-page":"eaav7259","DOI":"10.1126\/scisignal.aav7259","article-title":"Application of a MYC degradation screen identifies sensitivity to CDK9 inhibitors in KRAS-mutant pancreatic cancer","volume":"12","author":"Blake","year":"2019","journal-title":"Sci. Signal."},{"key":"10.1016\/j.chembiol.2020.10.001_bib8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13046-018-0704-8","article-title":"CDK9 inhibitors in acute myeloid leukemia","volume":"37","author":"Boffo","year":"2018","journal-title":"J.\u00a0Exp. Clin. Cancer Res."},{"key":"10.1016\/j.chembiol.2020.10.001_bib9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0039-128X(75)80023-7","article-title":"Methyltrienolone, a specific ligand for cellular androgen receptors","volume":"26","author":"Bonne","year":"1975","journal-title":"Steroids"},{"key":"10.1016\/j.chembiol.2020.10.001_bib10","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1021\/acschembio.6b00012","article-title":"Inhibition of zinc-dependent histone deacetylases with a chemically triggered electrophile","volume":"11","author":"Boskovic","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.chembiol.2020.10.001_bib11","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cell.2016.12.013","article-title":"Transcriptional addiction in cancer","volume":"168","author":"Bradner","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2020.10.001_bib12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.chembiol.2006.03.004","article-title":"A robust small-molecule microarray platform for screening cell lysates","volume":"13","author":"Bradner","year":"2006","journal-title":"Chem. Biol."},{"key":"10.1016\/j.chembiol.2020.10.001_bib13","doi-asserted-by":"crossref","first-page":"37305","DOI":"10.18632\/oncotarget.26468","article-title":"Antineoplastic effects of selective CDK9 inhibition with atuveciclib on cancer stem-like cells in triple-negative breast cancer","volume":"9","author":"Brisard","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.chembiol.2020.10.001_bib14","doi-asserted-by":"crossref","first-page":"21.29.21","DOI":"10.1002\/0471142727.mb2129s109","article-title":"ATAC-seq: a method for assaying chromatin accessibility genome-wide","volume":"109","author":"Buenrostro","year":"2015","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"10.1016\/j.chembiol.2020.10.001_bib15","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ccell.2019.01.008","article-title":"ARv7 represses tumor-suppressor genes in castration-resistant prostate cancer","volume":"35","author":"Cato","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.chembiol.2020.10.001_bib16","first-page":"365","article-title":"Mechanisms of resistance in castration-resistant prostate cancer (CRPC)","volume":"4","author":"Chandrasekar","year":"2015","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.chembiol.2020.10.001_bib17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1126\/science.aar4199","article-title":"Mediator and RNA polymerase II clusters associate in transcription-dependent condensates","volume":"361","author":"Cho","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2020.10.001_bib18","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1158\/1078-0432.CCR-19-1853","article-title":"AZD4573 is a highly selective CDK9 inhibitor that suppresses MCL-1 and induces apoptosis in hematologic cancer cells","volume":"26","author":"Cidado","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.chembiol.2020.10.001_bib19","first-page":"2645","article-title":"CT7001, a novel orally bio-available CDK7 inhibitor, is highly active in in-vitro and in-vivo models of AML","volume":"130","author":"Clark","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.chembiol.2020.10.001_bib80","doi-asserted-by":"crossref","first-page":"18787","DOI":"10.1073\/pnas.1012741107","article-title":"Small molecules of different origins have distinct distributions of structural complexity that correlate with protein-binding profiles","volume":"107","author":"Clemons","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.chembiol.2020.10.001_bib20","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/nmeth.4396","article-title":"An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues","volume":"14","author":"Corces","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.chembiol.2020.10.001_bib21","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nature21688","article-title":"Transcription control by the ENL YEATS domain in acute leukaemia","volume":"543","author":"Erb","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2020.10.001_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-1-61779-337-0_7","article-title":"Kinase inhibitor selectivity profiling using differential scanning fluorimetry","volume":"795","author":"Fedorov","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.chembiol.2020.10.001_bib23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1021\/acschembio.5b00577","article-title":"Small molecule microarrays enable the identification of a selective, quadruplex-binding inhibitor of MYC expression","volume":"11","author":"Felsenstein","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.chembiol.2020.10.001_bib24","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/jcb.26293","article-title":"CDK9: a key player in cancer and other diseases","volume":"119","author":"Franco","year":"2018","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.chembiol.2020.10.001_bib25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1515\/CCLM.2003.040","article-title":"Real-time RT-PCR for the measurement of prostate-specific antigen mRNA expression in benign hyperplasia and adenocarcinoma of prostate","volume":"41","author":"Gelmini","year":"2003","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.chembiol.2020.10.001_bib26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1515\/CCLM.2003.040","article-title":"Real-time RT-PCR for the measurement of prostate-specific antigen mRNA expression in benign hyperplasia and adenocarcinoma of prostate","volume":"41","author":"Gelmini","year":"2003","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.chembiol.2020.10.001_bib27","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/leu.2011.218","article-title":"TG02, a novel oral multi-kinase inhibitor of CDKs, JAK2 and FLT3 with potent anti-leukemic properties","volume":"26","author":"Goh","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.chembiol.2020.10.001_bib28","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41586-019-1464-0","article-title":"Pol II phosphorylation regulates a switch between transcriptional and splicing condensates","volume":"572","author":"Guo","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2020.10.001_bib29","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1158\/1535-7163.MCT-18-1023","article-title":"Cyclin-dependent kinase-9 is a therapeutic target in MYC-expressing diffuse large B-cell lymphoma","volume":"18","author":"Hashiguchi","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.chembiol.2020.10.001_bib81","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/nmeth.4435","article-title":"Thiol-linked alkylation of RNA to assess expression dynamics","volume":"14","author":"Herzog","year":"2017","journal-title":"Nat Methods"},{"key":"10.1016\/j.chembiol.2020.10.001_bib30","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/jb\/mvm090","article-title":"Phosphorylation of the C-terminal domain of RNA polymerase II plays central roles in the integrated events of eucaryotic gene expression","volume":"141","author":"Hirose","year":"2007","journal-title":"J.\u00a0Biochem."},{"key":"10.1016\/j.chembiol.2020.10.001_bib31","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1158\/1078-0432.CCR-12-2910","article-title":"Enzalutamide: a novel antiandrogen for patients with castrate-resistant prostate cancer","volume":"19","author":"Hoffman-Censits","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.chembiol.2020.10.001_bib32","doi-asserted-by":"crossref","first-page":"e19059","DOI":"10.1371\/journal.pone.0019059","article-title":"Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival","volume":"6","author":"H\u00f6rnberg","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.chembiol.2020.10.001_bib33","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1158\/1538-7445.AM2019-4421","article-title":"Abstract 4421: SY-5609, an orally available selective CDK7 inhibitor demonstrates broad anti-tumor activity in\u00a0vivo","volume":"79","author":"Hu","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.chembiol.2020.10.001_bib34","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1101\/gad.244368.114","article-title":"CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma","volume":"28","author":"Huang","year":"2014","journal-title":"Genes Dev."},{"key":"10.1016\/j.chembiol.2020.10.001_bib35","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41588-020-0635-0","article-title":"Selective Mediator dependence of cell-type-specifying transcription","volume":"52","author":"Jaeger","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.chembiol.2020.10.001_bib36","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/nprot.2014.138","article-title":"The cellular thermal shift assay for evaluating drug target interactions in cells","volume":"9","author":"Jafari","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.chembiol.2020.10.001_bib37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrm3953","article-title":"Getting up to speed with transcription elongation by RNA polymerase II","volume":"16","author":"Jonkers","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.chembiol.2020.10.001_bib38","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1038\/onc.2013.206","article-title":"Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches","volume":"32","author":"Karantanos","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.chembiol.2020.10.001_bib39","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1158\/1538-7445.AM2019-4407","article-title":"Abstract 4407: next generation CDK2\/9 inhibitor CYC065 triggers anaphase catastrophe in diverse aneuploid cancers and markedly inhibits growth and metastasis","volume":"79","author":"Kawakami","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.chembiol.2020.10.001_bib40","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1158\/1538-7445.AM2017-5133","article-title":"Abstract 5133: TP-1287, an oral prodrug of the cyclin-dependent kinase-9 inhibitor alvocidib","volume":"77","author":"Kim","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.chembiol.2020.10.001_bib41","doi-asserted-by":"crossref","first-page":"T131","DOI":"10.1530\/ERC-13-0472","article-title":"Androgen receptor phosphorylation: biological context and functional consequences","volume":"21","author":"Koryakina","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.chembiol.2020.10.001_bib42","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nature13393","article-title":"Targeting transcription regulation in cancer with a covalent CDK7 inhibitor","volume":"511","author":"Kwiatkowski","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2020.10.001_bib43","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1080\/13543784.2019.1678583","article-title":"Cyclin-dependent kinase (CDK) 9 and 4\/6 inhibitors in acute myeloid leukemia (AML): a promising therapeutic approach","volume":"28","author":"Lee","year":"2019","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.chembiol.2020.10.001_bib44","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1242\/dev.091744","article-title":"Cdks, cyclins and CKIs: roles beyond cell cycle regulation","volume":"140","author":"Lim","year":"2013","journal-title":"Development"},{"key":"10.1016\/j.chembiol.2020.10.001_bib45","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.ajpath.2012.06.008","article-title":"KLF6 loss of function in human prostate cancer progression is implicated in resistance to androgen deprivation","volume":"181","author":"Liu","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.chembiol.2020.10.001_bib46","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","article-title":"Selective inhibition of tumor oncogenes by disruption of super-enhancers","volume":"153","author":"Lov\u00e9n","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2020.10.001_bib47","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/cmdc.201700447","article-title":"Identification of atuveciclib (BAY1143572), the first highly selective, clinical PTEFb\/CDK9 inhibitor for the treatment of cancer","volume":"12","author":"L\u00fccking","year":"2017","journal-title":"ChemMedChem"},{"key":"10.1016\/j.chembiol.2020.10.001_bib48","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/gb4184","article-title":"Cyclin-dependent kinases","volume":"15","author":"Malumbres","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.chembiol.2020.10.001_bib49","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1233606","article-title":"Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay","volume":"341","author":"Martinez Molina","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2020.10.001_bib50","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1039\/C1MB05249G","article-title":"Intrinsic disorder in the androgen receptor: identification, characterisation and drugability","volume":"8","author":"McEwan","year":"2012","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.chembiol.2020.10.001_bib51","doi-asserted-by":"crossref","first-page":"9069","DOI":"10.18632\/oncotarget.6997","article-title":"CDK9 inhibitors selectively target estrogen receptor-positive breast cancer cells through combined inhibition of MYB and MCL-1 expression","volume":"7","author":"Mitra","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.chembiol.2020.10.001_bib52","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/15384101.2016.1138186","article-title":"Overview of CDK9 as a target in cancer research","volume":"15","author":"Morales","year":"2016","journal-title":"Cell Cycle"},{"key":"10.1016\/j.chembiol.2020.10.001_bib53","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1126\/science.aao2793","article-title":"SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis","volume":"360","author":"Muhar","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2020.10.001_bib54","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12859-019-2849-7","article-title":"Quantification of experimentally induced nucleotide conversions in high-throughput sequencing datasets","volume":"20","author":"Neumann","year":"2019","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.chembiol.2020.10.001_bib55","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nchembio.2538","article-title":"Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation","volume":"14","author":"Olson","year":"2018","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.chembiol.2020.10.001_bib56","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.chembiol.2019.02.012","article-title":"Development of a selective CDK7 covalent inhibitor reveals predominant cell-cycle phenotype","volume":"26","author":"Olson","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.chembiol.2020.10.001_bib57","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41586-019-1347-4","article-title":"Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer","volume":"571","author":"Parolia","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2020.10.001_bib58","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1158\/1535-7163.MCT-13-0689","article-title":"A small molecule that binds and inhibits the ETV1 transcription factor oncoprotein","volume":"13","author":"Pop","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.chembiol.2020.10.001_bib59","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/9780470559277.ch140101","article-title":"Probing small-molecule microarrays with tagged proteins in cell lysates","volume":"6","author":"Pop","year":"2014","journal-title":"Curr. Protoc. Chem. Biol."},{"key":"10.1016\/j.chembiol.2020.10.001_bib60","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.cell.2010.03.030","article-title":"c-Myc regulates transcriptional pause release","volume":"141","author":"Rahl","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2020.10.001_bib61","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1158\/0008-5472.CAN-08-3415","article-title":"Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells","volume":"69","author":"Scharer","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.chembiol.2020.10.001_bib62","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/nmeth.3542","article-title":"ChIPmentation: fast, robust, low-input ChIP-seq for histones and transcription factors","volume":"12","author":"Schmidl","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.chembiol.2020.10.001_bib63","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13045-015-0225-2","article-title":"Persistent androgen receptor addiction in castration-resistant prostate cancer","volume":"8","author":"Schweizer","year":"2015","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.chembiol.2020.10.001_bib64","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/s41591-018-0312-3","article-title":"Small-molecule targeting of brachyury transcription factor addiction in chordoma","volume":"25","author":"Sharifnia","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.chembiol.2020.10.001_bib65","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1172\/JCI122819","article-title":"Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer","volume":"129","author":"Sharp","year":"2019","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.chembiol.2020.10.001_bib66","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.chembiol.2020.10.001_bib67","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nchembio.142","article-title":"A small molecule that binds Hedgehog and blocks its signaling in human cells","volume":"5","author":"Stanton","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.chembiol.2020.10.001_bib68","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.chembiol.2019.02.009","article-title":"Stabilization of the max homodimer with a small molecule attenuates Myc-driven transcription","volume":"26","author":"Struntz","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.chembiol.2020.10.001_bib69","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3389\/fonc.2019.01205","article-title":"Transcriptional silencing of MCL-1 through cyclin-dependent kinase inhibition in acute myeloid leukemia","volume":"9","author":"Tibes","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.chembiol.2020.10.001_bib70","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1126\/science.1168175","article-title":"Development of a second-generation antiandrogen for treatment of advanced prostate cancer","volume":"324","author":"Tran","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2020.10.001_bib71","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1021\/jm970124v","article-title":"Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(phenylamino)pyrazolo[3,4-d]pyrimidines","volume":"40","author":"Traxler","year":"1997","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.chembiol.2020.10.001_bib72","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0163-7258(98)00044-8","article-title":"Strategies toward the design of novel and selective protein tyrosine kinase inhibitors","volume":"82","author":"Traxler","year":"1999","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.chembiol.2020.10.001_bib73","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1039\/b703568n","article-title":"Small-molecule microarrays as tools in ligand discovery","volume":"37","author":"Vegas","year":"2008","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.chembiol.2020.10.001_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2018.06.005","article-title":"MAFG is a potential therapeutic target to restore chemosensitivity in cisplatin-resistant cancer cells by increasing reactive oxygen species","volume":"200","author":"Vera-Puente","year":"2018","journal-title":"Transl. Res."},{"key":"10.1016\/j.chembiol.2020.10.001_bib75","doi-asserted-by":"crossref","first-page":"111535","DOI":"10.1016\/j.ejmech.2019.07.038","article-title":"Novel cyclin-dependent kinase 9 (CDK9) inhibitor with suppression of cancer stemness activity against non-small-cell lung cancer","volume":"181","author":"Wang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.chembiol.2020.10.001_bib76","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.cell.2017.11.008","article-title":"YY1 is a structural regulator of enhancer- promoter loops","volume":"171","author":"Weintraub","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2020.10.001_bib77","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.molcel.2017.06.004","article-title":"BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment","volume":"67","author":"Winter","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.chembiol.2020.10.001_bib78","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.cell.2018.09.051","article-title":"Targeting CDK9 reactivates epigenetically silenced genes in cancer","volume":"175","author":"Zhang","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2020.10.001_bib79","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/nchembio.2166","article-title":"Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors","volume":"12","author":"Zhang","year":"2016","journal-title":"Nat. Chem. Biol."}],"container-title":["Cell Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945620303809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945620303809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:49:52Z","timestamp":1778888992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451945620303809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S2451945620303809"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2020.10.001","relation":{},"ISSN":["2451-9456"],"issn-type":[{"value":"2451-9456","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulating Androgen Receptor-Driven Transcription in Prostate Cancer with Selective CDK9 Inhibitors","name":"articletitle","label":"Article Title"},{"value":"Cell Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2020.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}